About Sensydia
Sensydia is a company based in Los Angeles (United States) founded in 2015. Sensydia has raised $17.8 million across 6 funding rounds from investors including NIH, HHS and Orlando Health. Sensydia offers products and services including Cardiac Performance System and Disposable Sensors. Sensydia operates in a competitive market with competitors including iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
- Headquarter Los Angeles, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sensydia Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.8 M (USD)
in 6 rounds
-
Latest Funding Round
$3 M (USD), Grant
Jun 05, 2023
-
Investors
NIH
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sensydia
Sensydia offers a comprehensive portfolio of products and services, including Cardiac Performance System and Disposable Sensors.
Non-invasive platform for measuring cardiac metrics in clinical settings.
Components for accurate hemodynamic data acquisition in patient care.
People of Sensydia
Unlock access to complete
Unlock access to complete
Leadership Team
2 people
CTO Team
1 people
Advisor Team
1 people
CMO Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Sensydia
Sensydia has successfully raised a total of $17.8M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $3 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sensydia
Sensydia has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Orlando Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to tech startups by Colle Capital.
|
Locked | Locked | Locked | |
|
Early-stage investments are targeted by this venture capital firm.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Sensydia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sensydia
Investment portfolio details for Sensydia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sensydia
Detailed financials for Sensydia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sensydia Comparisons
Peer comparison for Sensydia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sensydia
Sensydia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Online health and wellness tracking and training platform
|
Detailed competitors of Sensydia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sensydia
Complete news archive for Sensydia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sensydia
Sensydia was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Sensydia is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Anthony Arnold is the current CEO of Sensydia.
Sensydia is a funded company, having raised a total of $17.8M across 6 funding rounds to date.
Sensydia was founded in 2015 in Los Angeles, United States, within the health technology sector. A wireless, non-invasive device for cardio-respiratory monitoring is being developed to allow real-time measurement of heart function in patients. Operations are maintained in stealth mode, with focus on medical device innovation for clinical applications. The company is led by CEO Anthony Arnold.
Sensydia's top competitors include AliveCor, iRhythm Tech and Biotricity.
Sensydia offers Cardiac Performance System and Disposable Sensors.
Sensydia has 5 investors. Key investors include NIH, HHS, Orlando Health, Colle Capital, and Frontier Venture Capital.